CELMoD
Showing 1 - 10 of 10
Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV Trial in Australia (BMS-986369,
Not yet recruiting
- Follicular Lymphoma Stage II
- +2 more
- BMS-986369
- +2 more
-
Ballarat, Victoria, Australia
- +4 more
Mar 15, 2023
Multiple Myeloma Trial in Duarte (Biospecimen Collection, Bone Marrow Aspiration, Computed Tomography)
Recruiting
- Multiple Myeloma
- Biospecimen Collection
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 21, 2023
Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Columbus (procedure, drug, biological)
Not yet recruiting
- Recurrent Multiple Myeloma
- Refractory Multiple Myeloma
- Biospecimen Collection
- +9 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 1, 2023
Relapsed and Refractory Multiple Myeloma Trial in Pittsburgh (Mezigdomide, Ixazomib, Dexamethasone)
Not yet recruiting
- Relapsed and Refractory Multiple Myeloma
- Mezigdomide
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Sep 15, 2023
HER2-positive Breast Cancer, HER-2 Protein Overexpression, HER-2 Gene Amplification Trial in San Antonio, Fairfax (ORM-5029)
Not yet recruiting
- HER2-positive Breast Cancer
- +3 more
-
San Antonio, Texas
- +1 more
Aug 22, 2022
Multiple Myeloma Trial in Netherlands (Iberdomide plus low-dose cyclophosphamide and dexamethasone)
Recruiting
- Multiple Myeloma
- Iberdomide plus low-dose cyclophosphamide and dexamethasone
-
Alkmaar, Netherlands
- +8 more
Oct 5, 2021
Multiple Myeloma Trial in Spain, United States (BB2121, CC-220, BMS-986405)
Recruiting
- Multiple Myeloma
- BB2121
- +2 more
-
Birmingham, Alabama
- +33 more
Jan 26, 2023